Maria Lopez Case Study: Clinical Management of Generalized Anxiety Disorder
Patient Profile and Initial Presentation
- Patient Name: Maria Lopez.
- Age: 34 years old.
- Gender: Female.
- Ethnicity: Hispanic.
- Occupation: Elementary school teacher.
- Marital Status: Married.
- Living Situation: Lives with husband and two children, ages 6 and 4.
- Chief Complaint: "I just feel constantly anxious and on edge. I can't relax anymore."
History of Present Illness (HPI)
- Duration: The patient reports worsening anxiety for the past 6 months.
- Symptom Characteristics:
- Characterized by excessive worry occurring nearly every day.
- Associated symptoms include restlessness, fatigue, muscle tension, difficulty concentrating, and insomnia (difficulty falling or staying asleep).
- Triggers: The patient cannot pinpoint anything specific in her life causing the anxiety; there are no new significant life stressors.
- Impact on Functioning: Symptoms interfere significantly with both work and family life.
- Review of Systems (Constitutional/Psychiatric):
- Positive findings: Anxiety, fatigue, muscle tension, and insomnia.
- Negative findings: Denial of panic attacks, suicidal ideation (SI), homicidal ideation (HI), hallucinations, and delusions.
- Negative for weight loss, chest pain, and shortness of breath.
- Psychosomatic considerations: The patient denies heart palpitations, tingling in hands, or shortness of breath (symptoms typically indicative of panic).
Standardized Assessment Scores
- Generalized Anxiety Disorder-7 (GAD-7): The patient scored 15.
- Patient Health Questionnaire-9 (PHQ-9): The patient scored 6.
- Interpretation: A score of 15 on the GAD-7 suggests severe anxiety. A score of 6 on the PHQ-9 suggests mild depressive symptoms, which often overlap with anxiety disorders.
Medical and Family History
- Past Medical History (PMH): Significant for hypothyroidism.
- Current Medications:
- Levothyroxine: 75μg daily.
- Multivitamin: Once daily.
- Allergies: No known medication allergies.
- Family History:
- Mother: History of depression.
- Sister: History of anxiety.
- Social History:
- Alcohol Use: Drinks 2 glasses of wine on weekends.
- Tobacco/Illicit Drug Use: Denies use.
- Exercise: Currently does not exercise.
- Safety: Feels safe at home.
Differential Diagnoses
- Generalized Anxiety Disorder (GAD): Primary diagnosis based on the persistence and nature of symptoms for over 6 months.
- Panic Disorder: Considered due to psychosomatic complaints common in anxiety, though ruled out by the patient's denial of specific panic attack symptoms.
- Hypothyroidism/Hyperthyroidism (Medication-Induced): Investigating if current levothyroxine levels are too high, causing iatrogenic hyperthyroidism (anxiety-mimicking symptoms).
- Mild Depressive Disorder: Suggested by the subthreshold PHQ-9 score.
- Adjustment Disorder with Anxiety: Considered if a trigger were present, though less likely as the patient denies specific stressors.
- Cardiac Event: Rule out based on lack of chest pain or palpitations.
Diagnostic and Laboratory Plan
- Thyroid Stimulating Hormone (TSH): Necessary to check stability on levothyroxine, ideally with reflex to Free T3 and T4.
- Complete Blood Count (CBC): To screen for anemia or infection contributing to fatigue.
- Comprehensive Metabolic Panel (CMP): To assess kidney and liver function and electrolyte balance.
- Electrocardiogram (EKG): Discussed but deemed unnecessary for this specific patient due to the absence of cardiac risk factors or clinical symptoms like palpitations or chest pain.
- Pregnancy Test: Recommended for women of childbearing age before starting certain medications, depending on contraceptive use.
- Gastrointestinal Assessment: Importance of assessing the "gut-brain axis" by asking about nausea, vomiting, or changes in bowel movements.
Therapeutic Plan: Non-Pharmacological Interventions
- Cognitive Behavioral Therapy (CBT): The most research-backed counseling approach in conjunction with medication. A referral should be provided.
- Sleep Hygiene: Essential due to reported insomnia; focus on regular schedules and environments.
- Exercise: Recommend small, manageable goals (e.g., 5 minutes outside) to improve mood and reduce anxiety.
- Lifestyle Modifications: Limit caffeine intake and reduce alcohol consumption.
- Mindfulness: Practice deep breathing exercises and identifying triggers.
- Safety Planning/Support Network: Identifying resources and people to contact during high-stress periods to ensure the patient does not feel alone.
Therapeutic Plan: Pharmacological Management
- Selective Serotonin Reuptake Inhibitors (SSRIs): First-line therapy.
- Sertraline (Zoloft): Start at a low dose of 25mg.
- Escitalopram (Lexapro): Recommended dose of 10mg, potentially starting at 5mg for the first week.
- Side Effects to Monitor: Nausea, diarrhea, insomnia, and initial feelings of "dysregulation."
- Treatment Timeline:
- Initial response takes 2 to 4 weeks.
- Full therapeutic effect occurs at 4 to 6 weeks (sometimes up to 8 weeks).
- Benzodiazepines (e.g., Xanax, Ativan): Not recommended for general anxiety disorder due to risk of dependence and difficulty with withdrawal. May be used very short-term (bridge therapy) but generally avoided as they are not first-line.
- Alternatives for Crisis/Sleep: Hydroxyzine or Propranolol (the latter for physical symptoms like palpitations).
Physical Examination Findings
- Constitutional: Patient is alert and cooperative.
- Psychiatric: Patient appears mildly anxious. Mood is recorded as "anxious." Affect is congruent with mood.
- Cardiovascular: Heart sounds S1 and S2 present with no murmurs, gallops, or rubs.
- Respiratory: Lungs clear to auscultation bilaterally.
Follow-up and Compliance
- Follow-up Interval: Reassess in 4 to 6 weeks to evaluate the effectiveness of medication and labs.
- Prescription Dosing: Provide only a 30-day supply initially to ensure the patient returns for follow-up and to mitigate risks of overdose in patients with depressive symptoms.
- Patient Education:
- Normalize anxiety as a treatable condition to reduce stigma.
- Stress the importance of adherence; do not stop medication abruptly to avoid rebound anxiety or neurological withdrawal symptoms.
- Tapering off may be considered after approximately 6 months of symptom stability.
Questions & Discussion
- Patient Red Red Flags: Questions were raised regarding suicidal ideation (SI), homicidal ideation (HI), and psychosis. These must always be assessed.
- Diagnostic Redundancy: Discussion of avoiding repetitive questioning during Objective Structured Clinical Examinations (OSCEs) by separating the HPI and Review of Systems (ROS) effectively.
- Clinical Hours Tracking: Mention of clinical hour reports via systems like Trellis and Exact.
- SANE Training: Discussion regarding 40 clinical hours for Sexual Assault Nurse Examiner (SANE) training being used toward clinical requirements.
- Preceptor Coordination: Clarification on designating a main preceptor in systems like Exact when working at sites with multiple providers (e.g., Healthtopia).